218 related articles for article (PubMed ID: 16236491)
1. Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease.
Dransfield MT; Davis JJ; Gerald LB; Bailey WC
Respir Med; 2006 Jun; 100(6):1110-6. PubMed ID: 16236491
[TBL] [Abstract][Full Text] [Related]
2. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
[TBL] [Abstract][Full Text] [Related]
3. Smoking patterns in African Americans and whites with advanced COPD.
Chatila WM; Wynkoop WA; Vance G; Criner GJ
Chest; 2004 Jan; 125(1):15-21. PubMed ID: 14718415
[TBL] [Abstract][Full Text] [Related]
4. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease.
Albert P; Agusti A; Edwards L; Tal-Singer R; Yates J; Bakke P; Celli BR; Coxson HO; Crim C; Lomas DA; Macnee W; Miller B; Rennard S; Silverman EK; Vestbo J; Wouters E; Calverley P
Thorax; 2012 Aug; 67(8):701-8. PubMed ID: 22696176
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
[TBL] [Abstract][Full Text] [Related]
6. Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study.
Powell R; Davidson D; Divers J; Manichaikul A; Carr JJ; Detrano R; Hoffman EA; Jiang R; Kronmal RA; Liu K; Punjabi NM; Shahar E; Watson KE; Rotter JI; Taylor KD; Rich SS; Barr RG
Thorax; 2013 Jul; 68(7):634-642. PubMed ID: 23585509
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in COPD: are women more susceptible to smoking effects than men?
Sørheim IC; Johannessen A; Gulsvik A; Bakke PS; Silverman EK; DeMeo DL
Thorax; 2010 Jun; 65(6):480-5. PubMed ID: 20522842
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in antioxidant enzymes, cigarette smoking, and longitudinal change in lung function.
Tang W; Bentley AR; Kritchevsky SB; Harris TB; Newman AB; Bauer DC; Meibohm B; Cassano PA;
Free Radic Biol Med; 2013 Oct; 63():304-12. PubMed ID: 23688726
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
Zhang J; Lin XF; Bai CX
Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
[TBL] [Abstract][Full Text] [Related]
10. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment.
Kirkpatrick dP; Dransfield MT
Curr Opin Pulm Med; 2009 Mar; 15(2):100-4. PubMed ID: 19532023
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in quality of life in patients with COPD.
Han MK; Curran-Everett D; Dransfield MT; Criner GJ; Zhang L; Murphy JR; Hansel NN; DeMeo DL; Hanania NA; Regan EA; Make BJ; Martinez FJ; Westney GE; Foreman MG;
Chest; 2011 Nov; 140(5):1169-1176. PubMed ID: 21636665
[TBL] [Abstract][Full Text] [Related]
12. Gender and chronic obstructive pulmonary disease in high-risk smokers.
de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Patients with Chronic Obstructive Pulmonary Disease Exposed to Different Environmental Risk Factors: A Large Cross-Sectional Study.
Duan JX; Cheng W; Zeng YQ; Chen Y; Cai S; Li X; Zhu YQ; Chen M; Zhou ML; Ma LB; Liu QM; Chen P
Int J Chron Obstruct Pulmon Dis; 2020; 15():2857-2867. PubMed ID: 33192059
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
[TBL] [Abstract][Full Text] [Related]
15. Factor analysis in predominantly severe COPD: identification of disease heterogeneity by easily measurable characteristics.
Postma DS; Anzueto AR; Jenkins C; Make BJ; Similowski T; Östlund O; Eriksson GS; Calverley PM
Respir Med; 2013 Dec; 107(12):1939-47. PubMed ID: 23953956
[TBL] [Abstract][Full Text] [Related]
16. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysis.
Burney P; Jithoo A; Kato B; Janson C; Mannino D; Nizankowska-Mogilnicka E; Studnicka M; Tan W; Bateman E; Koçabas A; Vollmer WM; Gislason T; Marks G; Koul PA; Harrabi I; Gnatiuc L; Buist S;
Thorax; 2014 May; 69(5):465-73. PubMed ID: 24353008
[TBL] [Abstract][Full Text] [Related]
17. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
18. Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers.
Sadeghnejad A; Ohar JA; Zheng SL; Sterling DA; Hawkins GA; Meyers DA; Bleecker ER
Respir Res; 2009 Mar; 10(1):21. PubMed ID: 19284602
[TBL] [Abstract][Full Text] [Related]
19. Effect of smoking on spirometry of African American and White subjects.
Berry OF; Bhagat R; Ajelabi AA; Petrini MF
Chest; 2008 Dec; 134(6):1231-1236. PubMed ID: 18641113
[TBL] [Abstract][Full Text] [Related]
20. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
